Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03506997
Title Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (PERSEUS1)
Acronym PERSEUS1
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Institute of Cancer Research, United Kingdom
Age Groups: senior | adult
Covered Countries GBR

Additional content available in CKB BOOST